To investigate the effect on cognitive performance, safety and tolerability of an investigational product as an add-on to donepezil in mild to moderate Alzheimer’s disease.
- 1-2 Screening visits
- 7 follow-up visits
- Age: (55 and older)
- Existing diagnosis of Mild-Moderate Alzheimer’s disease
Access to investigational product for the research intervention of memory disturbance associated with Alzheimer's disease.
If you are interested in volunteering for this trial, call the Institute for Dementia Research and Prevention at 225-763-2973 or email email@example.com